JP2010536380A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536380A5
JP2010536380A5 JP2010522029A JP2010522029A JP2010536380A5 JP 2010536380 A5 JP2010536380 A5 JP 2010536380A5 JP 2010522029 A JP2010522029 A JP 2010522029A JP 2010522029 A JP2010522029 A JP 2010522029A JP 2010536380 A5 JP2010536380 A5 JP 2010536380A5
Authority
JP
Japan
Prior art keywords
strand
dsrna
seq
vector
ribonucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010522029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536380A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/073872 external-priority patent/WO2009026445A2/en
Publication of JP2010536380A publication Critical patent/JP2010536380A/ja
Publication of JP2010536380A5 publication Critical patent/JP2010536380A5/ja
Pending legal-status Critical Current

Links

JP2010522029A 2007-08-21 2008-08-21 転写後遺伝子サイレンシングのための方法及び組成物 Pending JP2010536380A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95709707P 2007-08-21 2007-08-21
PCT/US2008/073872 WO2009026445A2 (en) 2007-08-21 2008-08-21 Methods and compositions for post-transcriptional gene silencing

Publications (2)

Publication Number Publication Date
JP2010536380A JP2010536380A (ja) 2010-12-02
JP2010536380A5 true JP2010536380A5 (enExample) 2011-10-06

Family

ID=40378991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010522029A Pending JP2010536380A (ja) 2007-08-21 2008-08-21 転写後遺伝子サイレンシングのための方法及び組成物

Country Status (6)

Country Link
US (1) US20100186102A1 (enExample)
EP (1) EP2185702A4 (enExample)
JP (1) JP2010536380A (enExample)
AU (1) AU2008288846A1 (enExample)
CA (1) CA2697055A1 (enExample)
WO (1) WO2009026445A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339050B (es) * 2009-12-18 2016-05-09 Novartis Ag Composiciones organicas para tratar las enfermedades relacionadas con hsf1.
US20120308642A1 (en) * 2011-05-27 2012-12-06 Xavier University Of Louisiana Inhibiting hepatitis c viral replication with sirna combinations
US20140351961A1 (en) * 2011-08-31 2014-11-27 Alexzander A. Asea Compositions and methods for treatment of metastatic cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080023768A (ko) * 2000-03-30 2008-03-14 화이트헤드 인스티튜트 포 바이오메디칼 리서치 Rna 간섭의 rna 서열 특이적인 매개체
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna

Similar Documents

Publication Publication Date Title
JP7252328B2 (ja) Rnaを編集する方法および組成物
JP6745272B2 (ja) 核酸を細胞内へ導入するための組成物
JP2013535212A5 (enExample)
CN103403189B (zh) 用于稳定的多价RNA纳米颗粒中的pRNA多价连接域
JP2010512747A5 (enExample)
JP2018530530A5 (enExample)
EP4527459A3 (en) Nucleic acid, composition and conjugate containing nucleic acid, preparation method therefor and use thereof
JP2018512041A5 (enExample)
JP2017510542A5 (enExample)
RU2016123086A (ru) Способы и композиции для лечения болезни хантингтона
JP2018512110A5 (enExample)
JP2014527401A5 (enExample)
JP2008056679A5 (enExample)
HRP20201200T1 (hr) OLIGONUKLEOTIDNI SPOJEVI ZA CILJANJE HUNTINGTIN mRNK
WO2011056005A3 (ko) 안티센스 가닥에 의한 오프-타겟 효과를 최소화한 신규한 siRNA 구조 및 그 용도
JP2009102380A5 (ja) dsRNAを含む、ウイルス感染又は望ましくない細胞増殖によって媒介されるか又は誘導される病気又は疾患の治療用組成物
JP2018513668A5 (enExample)
JP2017093448A5 (enExample)
JP2014509511A5 (enExample)
JP2005518803A5 (enExample)
JP2012223202A5 (enExample)
JP2015142558A5 (enExample)
JP2012505657A5 (enExample)
WO2008115851A3 (en) Rnai therapeutic for respiratory virus infection
JP2024531728A5 (enExample)